During a school outbreak investigation in Delhi, a 12-year-old girl presents with bilateral parotid swelling, fever (38.2°C), and mild trismus. She reports that a classmate had similar symptoms 2 weeks ago. The girl's immunization card shows she received two doses of MMR vaccine at ages 12 months and 18 months. Laboratory testing confirms mumps virus RNA by RT-PCR. What is the most likely explanation for vaccine failure in this case?

Explanation

## Mumps Vaccine Failure: Waning Immunity ### Clinical Context The patient has: - Confirmed mumps (bilateral parotitis + fever + RT-PCR positive) - Complete MMR vaccination schedule (2 doses at 12 and 18 months) - Age 12 years (10+ years post-second dose) - Exposure in a school outbreak setting This is a classic case of **secondary vaccine failure** due to waning immunity. ### Vaccine Efficacy and Waning Immunity | Aspect | Details | |--------|----------| | **MMR Mumps Component Efficacy** | 88–95% after 2 doses (immediate) | | **Waning Timeline** | Antibody levels decline gradually over 10–15 years | | **Age at Failure** | Most common 10+ years after second dose | | **Outbreak Context** | High viral load and prolonged exposure increase breakthrough risk | | **Serological Status** | May show low or borderline antibody titers despite prior vaccination | **Key Point:** Mumps vaccine-induced immunity **wanes over time**, particularly after 10 years. This is well-documented in the literature and is the primary reason some vaccinated individuals develop mumps during outbreaks. ### Why This Is the Best Answer **High-Yield:** - The patient is 12 years old and received the second dose at 18 months → 10.5 years have elapsed - This timeframe aligns perfectly with documented waning of mumps antibodies - Waning immunity is the **most common cause** of mumps in vaccinated individuals during outbreaks - The outbreak setting (high viral exposure) unmasks borderline immunity **Clinical Pearl:** Mumps waning immunity is **more pronounced than measles or rubella** because mumps vaccine-induced immunity is inherently less durable. This is why some countries recommend a booster dose in adolescence or adulthood, especially in outbreak settings. ### Mechanism of Waning Immunity ```mermaid flowchart TD A[MMR Vaccination at 12-18 months]:::action --> B[Initial high antibody titers]:::outcome B --> C[Antibody levels decline over 10-15 years]:::action C --> D{Viral Exposure}:::decision D -->|Low exposure| E[No clinical disease]:::outcome D -->|High exposure/outbreak| F[Breakthrough mumps]:::urgent F --> G[Confirmed by RT-PCR]:::outcome ``` ### Epidemiological Significance - Mumps outbreaks in vaccinated populations are well-recognized - Waning immunity explains clusters in schools, colleges, and military settings - Booster strategies are being considered in high-incidence regions - This is NOT vaccine failure in the traditional sense (primary failure) but rather **secondary failure** [cite:Park 26e Ch 7; Harrison 21e Ch 220]